{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:45:35Z","timestamp":1782920735429,"version":"3.54.5"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41375-026-03007-z","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T06:56:15Z","timestamp":1781506575000},"page":"1538-1541","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Response kinetics as a dynamic prognostic marker in patients with multiple myeloma"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8300-8179","authenticated-orcid":false,"given":"Hee Jeong","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung-Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon-Seok","family":"Eom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongheon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1252-5336","authenticated-orcid":false,"given":"Ho-Young","family":"Yhim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dok Hyun","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyungwoo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2591-7459","authenticated-orcid":false,"given":"Sung-Soo","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ja Min","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Rok","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2341-4911","authenticated-orcid":false,"given":"Ji Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Nam","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Jin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Sup","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yundeok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9714-9615","authenticated-orcid":false,"given":"Sang Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5878-8895","authenticated-orcid":false,"given":"Kihyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3756-796X","authenticated-orcid":false,"given":"Joon Ho","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Korean Multiple Myeloma Working Party (KMM2303)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"3007_CR1","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","volume":"33","author":"A Palumbo","year":"2015","unstructured":"Palumbo A, Avet-Loiseau H, Oliva S, Lokhorst HM, Goldschmidt H, Rosinol L, et al. Revised international staging system for multiple myeloma: a report from International Myeloma Working Group. J Clin Oncol. 2015;33:2863\u20139.","journal-title":"J Clin Oncol"},{"key":"3007_CR2","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1182\/blood-2007-01-067728","volume":"110","author":"F van Rhee","year":"2007","unstructured":"van Rhee F, Bolejack V, Hollmig K, Pineda-Roman M, Anaissie E, Epstein J, et al. High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis. Blood. 2007;110:827\u201332.","journal-title":"Blood"},{"key":"3007_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00577-2","volume":"11","author":"HJ Cho","year":"2021","unstructured":"Cho HJ, Jung SH, Jo JC, Lee YJ, Yoon SE, Park SS, et al. Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and (18)F-FDG PET\/CT. Blood Cancer J. 2021;11:190.","journal-title":"Blood Cancer J"},{"key":"3007_CR4","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1038\/leu.2012.127","volume":"26","author":"R Kuiper","year":"2012","unstructured":"Kuiper R, Broyl A, de Knegt Y, van Vliet MH, van Beers EH, van der Holt B, et al. A gene expression signature for high-risk multiple myeloma. Leukemia. 2012;26:2406\u201313.","journal-title":"Leukemia"},{"key":"3007_CR5","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1182\/hematology.2023000443","volume":"2023","author":"F Gay","year":"2023","unstructured":"Gay F, Bertuglia G, Mina R. A rational approach to functional high-risk myeloma. Hematol Am Soc Hematol Educ Program. 2023;2023:433\u201342.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"3007_CR6","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1007\/s00277-021-04407-0","volume":"100","author":"JH Lee","year":"2021","unstructured":"Lee JH, Park Y, Kang KW, Lee JJ, Lee HS, Eom HS, et al. Carfilzomib in addition to lenalidomide and dexamethasone in Asian patients with RRMM outside of a clinical trial. Ann Hematol. 2021;100:2051\u20139.","journal-title":"Ann Hematol"},{"key":"3007_CR7","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s12185-022-03479-6","volume":"117","author":"JH Lee","year":"2023","unstructured":"Lee JH, Kim SH, Kim HR, Min CK, Lee JJ, Shin HJ, et al. Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and\/or refractory multiple myeloma. Int J Hematol. 2023;117:225\u201335.","journal-title":"Int J Hematol"},{"key":"3007_CR8","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/ajh.25113","volume":"93","author":"PW Mellors","year":"2018","unstructured":"Mellors PW, Binder M, Buadi FK, Lacy MQ, Gertz MA, Dispenzieri A, et al. Time to plateau as a predictor of survival in newly diagnosed multiple myeloma. Am J Hematol. 2018;93:889\u201394.","journal-title":"Am J Hematol"},{"key":"3007_CR9","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1182\/bloodadvances.2019000432","volume":"3","author":"Y Yan","year":"2019","unstructured":"Yan Y, Mao X, Liu J, Fan H, Du C, Li Z, et al. The impact of response kinetics for multiple myeloma in the era of novel agents. Blood Adv. 2019;3:2895\u2013904.","journal-title":"Blood Adv"},{"key":"3007_CR10","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1038\/s41375-018-0091-3","volume":"32","author":"L Garderet","year":"2018","unstructured":"Garderet L, Laubach JP, Stoppa AM, Hari P, Cavo M, Ludwig H, et al. Association between response kinetics and outcomes in relapsed\/refractory multiple myeloma: analysis from TOURMALINE-MM1. Leukemia. 2018;32:2032\u20136.","journal-title":"Leukemia"},{"key":"3007_CR11","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/jha2.759","volume":"4","author":"PG Richardson","year":"2023","unstructured":"Richardson PG, Facon T, Venner CP, Bahlis NJ, Offner F, White D, et al. Late versus early response and depth of response are associated with improved outcomes in patients with newly diagnosed multiple myeloma enrolled in the TOURMALINE-MM2 trial. EJHaem. 2023;4:995\u20131005.","journal-title":"EJHaem"},{"key":"3007_CR12","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1182\/bloodadvances.2018022806","volume":"3","author":"N Tandon","year":"2019","unstructured":"Tandon N, Sidana S, Rajkumar SV, Gertz MA, Buadi FK, Lacy MQ, et al. Outcomes with early response to first-line treatment in patients with newly diagnosed multiple myeloma. Blood Adv. 2019;3:744\u201350.","journal-title":"Blood Adv"},{"key":"3007_CR13","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1080\/10428194.2022.2038376","volume":"63","author":"J Wang","year":"2022","unstructured":"Wang J, Arroyo-Suarez R, Dasari S, Sekaran K, Tse W. Early versus late response to daratumumab-based triplet therapies in patients with multiple myeloma: a pooled analysis of trials POLLUX, CASTOR and MAIA. Leuk Lymphoma. 2022;63:1669\u201377.","journal-title":"Leuk Lymphoma"},{"key":"3007_CR14","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nrc.2017.63","volume":"17","author":"C Pawlyn","year":"2017","unstructured":"Pawlyn C, Morgan GJ. Evolutionary biology of high-risk multiple myeloma. Nat Rev Cancer. 2017;17:543\u201356.","journal-title":"Nat Rev Cancer"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03007-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03007-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03007-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:57:29Z","timestamp":1782917849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03007-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":14,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["3007"],"URL":"https:\/\/doi.org\/10.1038\/s41375-026-03007-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7446348\/v1","asserted-by":"object"}]},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"24 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Institutional Review Board of Kyungpook National University Hospital (IRB 2023-04-033) and by the ethics committees of all participating centers, and was conducted in accordance with the Declaration of Helsinki. Informed consent was waived by the Institutional Review Board given the retrospective study design and the utilization of de-identified patient data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}